Entity Details

Primary name CLCN2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP51788
EntryNameCLCN2_HUMAN
FullNameChloride channel protein 2
TaxID9606
Evidenceevidence at protein level
Length898
SequenceStatuscomplete
DateCreated1996-10-01
DateModified2021-06-02

Ontological Relatives

GenesCLCN2

GO terms

Show/Hide Table
GOName
GO:0005247 voltage-gated chloride channel activity
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006821 chloride transport
GO:0032347 regulation of aldosterone biosynthetic process
GO:0034220 ion transmembrane transport
GO:0034707 chloride channel complex
GO:0034765 regulation of ion transmembrane transport
GO:0060041 retina development in camera-type eye
GO:0060689 cell differentiation involved in salivary gland development

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000644 CBS domainDomainDomain
IPR001807 Chloride channel, voltage gatedFamilyFamily
IPR002244 Chloride channel ClC-2FamilyFamily
IPR014743 Chloride channel, coreFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615651 OMIMLeukoencephalopathy with ataxia (LKPAT)An autosomal recessive neurologic disorder with a characteristic pattern of white matter abnormalities on brain MRI. Affected individuals have prominent signal abnormalities and decreased apparent diffusion coefficient values in the posterior limbs of the internal capsules, middle cerebral peduncles, pyramidal tracts in the pons, and middle cerebellar peduncles, suggesting myelin microvacuolation. Clinical features include ataxia and unstable gait. More variable abnormalities may include visual field defects, headaches, and learning disabilities. The disease is caused by variants affecting the gene represented in this entry.
605635 OMIMHyperaldosteronism, familial, 2 (HALD2)An autosomal dominant disorder characterized by elevated plasma aldosterone level and hypertension of varying severity even within members of the same family. Hypokalemia is observed in some patients. In HALD2, hypertension does not improve with glucocorticoid treatment. The disease is caused by variants affecting the gene represented in this entry.
607628 OMIMEpilepsy, idiopathic generalized 11 (EIG11)A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Disease susceptibility is associated with variants affecting the gene represented in this entry.
607628 OMIMEpilepsy, idiopathic generalized 11 (EIG11)A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Disease susceptibility may be associated with variants affecting the gene represented in this entry.
607628 OMIMEpilepsy, idiopathic generalized 11 (EIG11)A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB01046 LubiprostoneDrugbanksmall molecule
DB05514 CobiprostoneDrugbanksmall molecule